INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 132 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $14,196,000 | +11.3% | 940,753 | +12.4% | 0.00% | 0.0% |
| Q3 2016 | $12,752,000 | -58.4% | 836,751 | +6.1% | 0.00% | -60.0% |
| Q2 2016 | $30,619,000 | +52.7% | 788,743 | +9.3% | 0.01% | +66.7% |
| Q1 2016 | $20,055,000 | -45.7% | 721,394 | +5.1% | 0.00% | -50.0% |
| Q4 2015 | $36,911,000 | +67.4% | 686,198 | +24.6% | 0.01% | +50.0% |
| Q3 2015 | $22,052,000 | +33.8% | 550,758 | +6.8% | 0.00% | +33.3% |
| Q2 2015 | $16,476,000 | +49.8% | 515,689 | +11.9% | 0.00% | +50.0% |
| Q1 2015 | $11,002,000 | +236.5% | 460,724 | +148.7% | 0.00% | +100.0% |
| Q4 2014 | $3,270,000 | +27.9% | 185,257 | -0.6% | 0.00% | – |
| Q3 2014 | $2,556,000 | -24.1% | 186,461 | -6.6% | 0.00% | -100.0% |
| Q2 2014 | $3,366,000 | +2932.4% | 199,648 | +3176.1% | 0.00% | – |
| Q1 2014 | $111,000 | – | 6,094 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |